Search results
Phrenic Nerve Stimulation for Central Sleep Apnoea
Author(s):
Jonathan Na
,
Miguel Valderrábano
,
Paul Schurmann
Added:
2 months ago
Review Article
Author(s):
Tarek Bekfani
,
Joseph D Abraham
,
William T Abraham
Added:
6 months ago
Author(s):
Eugenio Carulli
,
Marialuisa Sveva Marozzi
,
Maria Cristina Carella
,
et al
Added:
6 months ago
Added:
6 months ago
Source:
Radcliffe Cardiology
Results from the Phase III VICTOR trial, presented at the European Society of Cardiology (ESC) Congress 2025 and published in The Lancet, show that vericiguat did not meet its primary endpoint in patients with chronic, stable heart failure with reduced ejection fraction (HFrEF).¹˒²Vericiguat is an oral, once-daily stimulator of soluble guanylate cyclase (sGC), an enzyme in the nitric oxide…
View more
Pharmacological Therapy of HFrEF in 2025
Author(s):
Massimo Mapelli
,
Filippo Maria Rubbo
,
Simona Costantino
,
et al
Added:
7 months ago
Review Article
Stavros Stavrakis
Research Area(s) / Expertise:
Job title: Associate Professor of Medicine; Laureate Chair in Molecular Medicine; Vice Chief, Cardiovascular Section
Author
Nerea Torres
Job title: Electrophysiologist
Author
Giselle Melendez
Research Area(s) / Expertise:
Job title: Assistant Professor
Author
Michael Knaut
Job title: Professor for Cardiac Surgery, University of Dresden
Author
Jesse Dawson
Job title: Professor of Stroke Medicine and Consultant Physician
Author
